192 related articles for article (PubMed ID: 38452831)
1. Multifunctionality of cyclodextrin-based polymeric nanoparticulate delivery systems for chemotherapeutics, combination therapy, and theranostics.
Devi LS; Casadidio C; Gigliobianco MR; Di Martino P; Censi R
Int J Pharm; 2024 Apr; 654():123976. PubMed ID: 38452831
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review.
Tian B; Hua S; Liu J
Carbohydr Polym; 2020 Mar; 232():115805. PubMed ID: 31952603
[TBL] [Abstract][Full Text] [Related]
3. Role of Cyclodextrins in Nanoparticle-Based Drug Delivery Systems.
Shelley H; Babu RJ
J Pharm Sci; 2018 Jul; 107(7):1741-1753. PubMed ID: 29625157
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications.
Zafar N; Fessi H; Elaissari A
Int J Pharm; 2014 Jan; 461(1-2):351-66. PubMed ID: 24342710
[TBL] [Abstract][Full Text] [Related]
5. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
Lakkakula JR; Maçedo Krause RW
Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs.
Duchene D; Cavalli R; Gref R
Curr Pharm Biotechnol; 2016; 17(3):248-55. PubMed ID: 26517333
[TBL] [Abstract][Full Text] [Related]
7. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review.
Mura P
Int J Pharm; 2020 Apr; 579():119181. PubMed ID: 32112928
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin-Based Polymeric Drug Delivery Systems for Cancer Therapy.
Li X; Liu J; Qiu N
Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987181
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.
Li J; Loh XJ
Adv Drug Deliv Rev; 2008 Jun; 60(9):1000-17. PubMed ID: 18413280
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Drug Carrier Systems Based on Cyclodextrin Supramolecular Assemblies and Polymers: Present and Perspectives.
Gonzalez-Gaitano G; Isasi JR; Velaz I; Zornoza A
Curr Pharm Des; 2017; 23(3):411-432. PubMed ID: 27855609
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Pharmaceutical and Biomedical Applications of Cyclodextrin-Capped Gold Nanoparticles.
Abdellatif AAH; Ahmed F; Mohammed AM; Alsharidah M; Al-Subaiyel A; Samman WA; Alhaddad AA; Al-Mijalli SH; Amin MA; Barakat H; Osman SK
Int J Nanomedicine; 2023; 18():3247-3281. PubMed ID: 37337575
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies.
Santos AC; Costa D; Ferreira L; Guerra C; Pereira-Silva M; Pereira I; Peixoto D; Ferreira NR; Veiga F
Drug Deliv Transl Res; 2021 Feb; 11(1):49-71. PubMed ID: 32441011
[TBL] [Abstract][Full Text] [Related]
15. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin complexes: Perspective from drug delivery and formulation.
Jacob S; Nair AB
Drug Dev Res; 2018 Aug; 79(5):201-217. PubMed ID: 30188584
[TBL] [Abstract][Full Text] [Related]
17. A New Approach for β-cyclodextrin Conjugated Drug Delivery System in Cancer Therapy.
Sheng TM; Kumar PV
Curr Drug Deliv; 2022; 19(3):266-300. PubMed ID: 34620064
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin-Based Nanosystems as Drug Carriers for Cancer Therapy.
Sivakumar PM; Peimanfard S; Zarrabi A; Khosravi A; Islami M
Anticancer Agents Med Chem; 2020; 20(11):1327-1339. PubMed ID: 31490765
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications.
van de Manakker F; Vermonden T; van Nostrum CF; Hennink WE
Biomacromolecules; 2009 Dec; 10(12):3157-75. PubMed ID: 19921854
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin-Based Polymeric Materials Bound to Corona Protein for Theranostic Applications.
Esmaeilpour D; Broscheit JA; Shityakov S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
